Antisoma zu alten Höhen ?

Antisoma leukaemia treatment to be fast-tracked
Thu 03 Jun 2010
 
LONDON (SHARECAST) - Cancer drug developer Antisoma’s Leukaemia treatment AS1413 has been granted Fast Track designation by the US Food and Drug Administration (FDA).

The Fast Track programme affords drugs that have shown the potential to meet an unmet medical need in serious or life-threatening diseases a speedier review process than would otherwise be the case.

‘We're very pleased to have gained FDA Fast Track status for AS1413,’ said Antisoma chief executive Glyn Edwards.

‘This drug could represent a major advance in the options available to patients with secondary AML [acute myeloid leukaemia], and we look forward to completing the ongoing phase III trial and sharing the data with FDA and other regulators.’ 

http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=3495656
 

Antisoma's AS1413 gains FDA Fast Track status for treatment of secondary acute myeloid leukaemia

http://finance.yahoo.com/news/...ns-FDA-iw-55357026.html?x=0&.v=1

Kurs bei 0,068

Aber die Taxen ziehen bereits an, in London steigt der Kurs gerade sehr stark.Schöne große Käufe!
Na dann mal los......

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

At the ASCO meeting we will have three presentations on AS1411, including updated findings from the first phase II clinical trial in AML and data from a phase II clinical trial in renal cancer.

events.jspargo.com/asco10/public/...defined&SubExpoCatIDs=

Antisoma@ASCO !

events.jspargo.com/asco10/public/...ch.aspx&BoothID=158744

Three presentations with relevance to AS1413 will be made at the American Society of Clinical Oncology (ASCO) Annual Meeting in June; abstracts will be available on the ASCO website (www.asco.org) from 20 May.

www.antisoma.com/asm/media/press/pr2010/2010-05-17/

chicago2010.asco.org/

A member of Antisoma's business development team will be present at the following conference(s):



ASCO, Chicago 4-8 June 2010

Euro-Biotech Forum, Paris 28-30 June 2010

schon länger auf meiner Watchlist...Na mal schauen ob die Fast Track Geschichte bissel Schwung in den Laden bringt....

ih.advfn.com/p.php?pid=squote&symbol=L^ASM

tut sich was...

ih.advfn.com/...&p=5&t=20&showctype=1&delay=1" style="max-width:560px" /> ih.advfn.com/...&p=0&t=20&showctype=1&delay=1" style="max-width:560px" />

über 5 Mio gehandelte Shares und ein Kursanstieg von knapp 20 Prozent:

aktien.onvista.de/kurse.html?ID_OSI=92421

Geld
0,074
Brief
0,078
Zeit
03.06. 16:27

Und die News sind noch brandaktuell...

weg flieg gleich....

In London werden dicke Brocken gehandelt...schön !!!

die Amis wissen nicht, was sie mit Antisoma anfangen sollen!

...kennen sie nicht und verpassen dadurch diese Möglichkeit...

6.15  +1.10  +21.78%  6.15 6.23 5,993,636 6.23 5.26 5.05 on 02-Jun-2010  
www.londonstockexchange.com/exchange/...=GB0055696032GBGBXSSMM

DER DECKEL FLIEGT WEG !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

ich hab jetzt eh keine zeit, da im moment wamu absolute priorität hat. ich schau gegen abend mal wieder rein. ich hoffe, dann haben wir schon die 0,10€. :D